Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

The mammalian transcription factor forkhead box M1 (FoxM1) is induced during G1 phase, with expression continuing through S phase and mitosis. Siomycin A is a peptide thiazole antibiotic, first isolated from S. sioyaensis, that interacts with the 23S rRNA of bacteria.1 It inhibits FoxM1 (IC50 = ~5 μM), preventing the expression of FoxM1-
WARNING This product is not for human or veterinary use.
1. 1H NMR spectral evidence for the structure and conformation of peptide antibiotic siomycin-
2. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res. 66(19), 9731-9735 (2006).
3. Thiazole antibiotics siomycin A and thiostrepton inhibit the transcriptional activity of FOXM1. Front. Oncol. 3, 150 (2013).
4. Siomycin A targets brain tumor stem cells partially through a MELK-
5. MELK-
6. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS One 4(5), e5592 (2009).